Pioneering the development of AI-enabled platform for in-vivo real-time cancer diagnosis, thus improving timely medical interventions
Endofotonics

MISSION


Provide real-time early gastrointestinal cancer diagnosis



VISION
     
Reduce cancer burden through earlier diagnosis


Company incorporated   
2013

MILESTONES

2014
Angel round raised     
IMDx lab prototype developed      
2015
2016
Pre-Series A round raised      
IMDx probe developed
     
2017
SPECTRA IMDx™ developed
& subsidiary in Shanghai, China set up
2019
IMDx engineering
prototype developed 
     
2018
2020
Commence clinical trials  
Sales outside China
2021
2022
Sales within China
.....................
.....................
.....................
........

|                            |                                     |                                              |
Singapore Main Office

67 Ayer Rajah Crescent, #03-01/02
LaunchPad @ onenorth, Singapore 139950
China, Shanghai Office

R51, 14th Floor, 800 Shangcheng Road,
Pudong District, Shanghai
            For any enquiries, please write to contact@endofotonics.com and we will get back to you as soon as possible.

Disclaimer: Endofotonics products shown in this website may not be registered, approved for sale, or available for purchase in all countries where the website is accessible. Please consult your local Endofotonics representative for more information. Prior to undergoing esophago-gastro-duodenoscopy (EGD) procedures, please consult your healthcare professional to provide you with the possible risk and benefits associated with SPECTRA IMDx™ System.

HOME                TEAM                    PRODUCT                    PUBLICATIONS                     CONTACT